Clearmind Medicine Inc.
CMND · NASDAQ
10/31/2024 | 10/31/2023 | 10/31/2022 | 10/31/2021 | |
|---|---|---|---|---|
| Market Cap | $237 | $296 | $4,180 | $2,707 |
| - Cash | $7 | $5 | $0 | $5 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $231 | $290 | $4,180 | $2,702 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$8 | -$9 | -$8 | -$4 |
| % Margin | – | – | – | – |
| Net Income | -$5 | -$12 | -$9 | -$4 |
| % Margin | – | – | – | – |
| EPS Diluted | -67.6 | -1,703.2 | -8,688 | -4,812 |
| % Growth | 96% | 80.4% | -80.5% | – |
| Operating Cash Flow | -$5 | -$6 | -$5 | -$3 |
| Capital Expenditures | $0 | $0 | -$0 | -$0 |
| Free Cash Flow | -$5 | -$6 | -$5 | -$3 |